Fitness Trends Global Deep Brain Stimulation Devices Market | Página 3

According to the Parkinson’s disease Foundation, as of 2016, over 10 million people are
suffering from Parkinson’s disease globally. The findings published by the organization showed
that incidence rate of PD increases with age and only 4% of people were diagnosed with PD
before the age of 50 years. According to the Parkinson’s disease Foundation, incidence rate of
PD in the U.S is as high as 60,000 each year. According to Parkinson’s Australia Inc., around
11,544 new cases of PD were diagnosed in Australia in 2014 and as per the statistics released
by Parkinson Canada, the number of people suffering from Parkinson’s disease in Canada is
expected to increase to over 163,700 by 2031 (double than the prevalence in 2011). Therefore,
increasing incidence of PD across the globe is projected to drive the deep brain stimulation
devices market growth.
Request For Customization of Research Report @
https://www.coherentmarketinsights.com/insight/request-customization/84
Key companies covered as a part of this study include Aleva Neurotherapeutics SA, Boston
Scientific Corporation, Medtronic, Inc., St. Jude Medical, Inc., Cyberonics, Inc., and Neuronetics
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: [phone]
Email: [e-mail]